The effect of specific hormones on fibrinolysis in pregnancy

Bonnar, 1981, Venous thromboembolism in pregnancy, Clin Obstet Gynecol, 8, 455 Treffers, 1983, Epidemiological observations of thromboembolic disease during pregnancy and in the puerperium in 56,022 women, Int J Gynecol Obstet, 21, 327, 10.1016/0020-7292(83)90024-3 Montella, 1993, Hypercoagulable states in pregnancy, Curr Obsted Med, 2, 141 Andreasen, 1990, Plasminogen activator inhibitors: hormonally regulated serpins, Mol Cell Endocrinol, 68, 1, 10.1016/0303-7207(90)90164-4 Estelles, 1994, Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation, Blood, 84, 143, 10.1182/blood.V84.1.143.143 Estelles, 1991, Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia, Am J Obstet Gynecol, 165, 138, 10.1016/0002-9378(91)90242-J Bonnar, 1990, Changes in the fibrinolytic system during pregnancy, Semin Thromb Hemost, 16, 221, 10.1055/s-2007-1002673 Biezenski, 1958, Fibrinolysis in normal pregnancy, J Clin Pathol, 11, 306, 10.1136/jcp.11.4.306 Kruihof, 1987, Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors, Blood, 69, 460, 10.1182/blood.V69.2.460.460 Lau, 1993, Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor, Am J Hematol, 44, 260, 10.1002/ajh.2830440408 Engebretsen, 1986, Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease, Thromb Res, 42, 713, 10.1016/0049-3848(86)90351-8 Hamsten, 1987, Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction, Lancet, 2, 3, 10.1016/S0140-6736(87)93050-9 Halligan, 1994, Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia, Br J Obstet Gynaecol, 101, 488, 10.1111/j.1471-0528.1994.tb13147.x Fujii, 1990, Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells, Thromb Haemost, 64, 412, 10.1055/s-0038-1647329 Quehenberger, 1993, Studies on oral contraceptives - induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells, Ann Hematol, 67, 33, 10.1007/BF01709663 Kooistra, 1990, Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables, Am J Obstet Gynecol, 163, 404, 10.1016/0002-9378(90)90591-T Leuven, 1987, Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems, J Lab Clin Med, 109, 631 Sabra, 1983, Hemostatic system changes induced by 50 mg and 30 mg estrogen/progestrogen oral contraceptives, J Reprod Med, 28, 85 Crutchley, 1981, Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids, Ann N Y Acad Sci, 370, 609, 10.1111/j.1749-6632.1981.tb29767.x Loskutoff, 1986, The dexamethasone induced inhibitor of plasminogen activator in hepatoma cells is antigenically related to an inhibitor produced by bovine aortic endothelial cells, Thromb Haemost, 55, 8, 10.1055/s-0038-1661436 Van Giezen, 1992, Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone, Ann N Y Acad Sci, 667, 199, 10.1111/j.1749-6632.1992.tb51616.x Van Giezen, 1992, Inhibition of fibrinolytic activity in vivo by dexamethasone is counterbalanced by an inhibition of platelet aggregation, Thromb Haemost, 68, 69, 10.1055/s-0038-1656320 VonEickstedt, 1988, Corticotrophins and corticosteroids, 812 Hadden, 1995, Adrenal disorders of pregnancy, Endocrinol Metab Clin North Am, 24, 139, 10.1016/S0889-8529(18)30056-2 Aron, 1990, Cushing's syndrome and pregnancy, Am J Obstet Gynecol, 162, 244, 10.1016/0002-9378(90)90859-6 Crowley, 1990, The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials, Br J Obstet Gynaecol, 97, 11, 10.1111/j.1471-0528.1990.tb01711.x